THE MOST READ
London pre-open: Stocks seen lower but vaccine news could provide a lift
London stocks were set to fall at the open on Wednesday following strong gains in the previous session, but sentiment was likely to get a boost from news the UK has approved Pfizer’s Covid-19 vaccine for rollout next week.
London close: Stocks claw back losses to finish in the green
London stocks closed in positive territory on Tuesday, with sentiment underpinned by vaccine hopes and solid UK and China manufacturing data.
Debenhams to be wound down as JD Sports ends rescue talks
It was a grim day for the UK retail sector as beleaguered department store chain Debenhams was set to be liquidated following failed rescue talks with JD Sports, just hours after Philip Green’s Arcadia retail group went into administration.
The UK is a buy, says Goldman Sachs
UK domestic equities are buy, Goldman Sachs said in a strategy note on Tuesday, as it pointed to a sharp economic recovery next year.
Scotgold pours first gold at Cononish
Scotland-focussed exploration and production company Scotgold Resources announced on Tuesday that first gold had been poured at its “high-grade, low-cost” Cononish gold and silver mine in the Scottish Grampian Mountains area.
London midday: Stocks extend gains on vaccine optimism, manufacturing data
London stocks had extended gains by midday on Tuesday, with sentiment underpinned by vaccine hopes and solid UK and China manufacturing data.
Grafton buys wooden staircase maker StairBox for £44m
Building materials distributor Grafton has announced the acquisition of bespoke wooden staircase manufacturer StairBox for £44m.
UK house prices accelerate at fastest pace since January 2015
Annual house price growth advanced at a pace of 6.5% last month, the highest rate seen in almost five years.
AstraZeneca sells cholesterol drug rights for up to $350m
AstraZeneca said it had agreed to sell the rights to its cholesterol treatment Crestor to Germany’s Grunenthal for up to $350m (£261m).